SYNTAX Trial Results
New England Journal of Medicine Links
Article: Percutaneous Coronary Intervention versus Coronary-Artery Bypass Grafting for Severe Coronary Artery Disease
Rountable Discussion: CABG vs. Stenting: Clinical Implications of the SYNTAX Trial
STS Press Release: SYNTAX Trial Results Confirm Better Outcomes Using Bypass Surgery for Complex Coronary Disease
Webcast: SYNTAX Trial Results, Michael J. Mack, MD
Report: 2009 Appropriateness Criteria for Coronary Revascularization
The professional organizations that represent cardiologists and cardiac surgeons have collaborated to produce this report, which includes a detailed, easy-to-use chart (below) that can be used by doctors and patients jointly to plot severity of the disease with overall health status and determine an appropriate treatment strategy.
Graphic: CABG vs. PCI Chart
Who are Cardiothoracic (CT) Surgeons?
What is The Society of Thoracic Surgeons?
Supporting Research & Publications
- Drug-Eluting Stents: Pushing the Envelope Beyond the Labels?, by Joseph P. Carrozza, Jr., MD, New England Journal of Medicine, January 2008.
- Drug-Eluting Stents vs. Coronary Artery Bypass Grafting in Multivessel Coronary Disease, by E.L. Hannan, PhD, et al, New England Journal of Medicine, January 2008.
- Coronary Artery Bypass is Superior to Drug-Eluting Stents in Multi-Vessel Coronary Artery Disease, by Robert A. Guyton, MD, The Annals of Thoracic Surgery 2006;81:1949-57.
- Coronary Artery Bypass Grafting is Still the Best Treatment for Multi-Vessel and Left Main Disease – But Patients Need to Know, by David P. Taggart, MD, PhD, The Annals of Thoracic Surgery 2006;82:1966-75.
